beam suntory stock symbol

Beam Suntory ist ein Spirituosenhersteller mit Sitz in Deerfield, Illinois, USA.Das Unternehmen gehört dem japanischen Getränkehersteller Suntory.Beam Suntory entstand, als Suntory im April 2014 das Spirituosenunternehmen Beam Inc. für 13,6 Milliarden US-Dollar kaufte. Chart. What's going on at Beam Therapeutics (NYSE:BEAM)? The acquisition was completed on April 30, 2014, for a final cost of about $16 billion – when it was also announced that Beam would become a subsidiary of Suntory named Beam Suntory. Payout Estimate. Beam Therapeutics does not have a long track record of dividend growth. Select market. Vote “Underperform” if you believe BEAM will underperform the S&P 500 over the long term. It has a research and clinical collaboration agreement with Magenta Therapeutics, Inc. Beam Therapeutics Inc. was founded in 2017 and is based in Cambridge, Massachusetts. Beam Global Asia Linkedin. FreakOut Holdings. Learn everything you need to know about successful options trading with this three-part video course. Freshworks. Top institutional investors include Endurance Wealth Management Inc. (0.00%). To see all exchange delays and terms of use please see disclaimer. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Learn about financial terms, types of investments, trading strategies and more. Baidu Analytics. 2, 2020 at 7:58 a.m. By. whiskey . Beam Therapeutics (BEAM) has the following price history information. STBFY Stock Price | Suntory Beverage & Food Ltd. ADR Stock Quote (U.S.: OTC) | MarketWatch. Beam Therapeutics does not currently pay a dividend. Symbol Type; Beam Therapeutics / Beam Therapeutics Inc. Common Stock: US XNAS: BEAM: EQ0000000064993591 Tradable: RHS: Fractional Shares: Listed: 2020-02-06 Beam Therapeutics Inc. BEAM: Tradable: Beam Therapeutics Inc: BEAM: BEAM THERAPEUTICS INC. NASDAQ: BEAM: stock Listing Status: Beam Therapeutics Inc. BEAM: S BEAM THERAPEUTICS INC COM: NSDQ: BEAM: EQ Some companies that are related to Beam Therapeutics include BioNTech (BNTX), Novozymes A/S (NVZMY), CRISPR Therapeutics (CRSP), argenx (ARGX), Bio-Techne (TECH), QIAGEN (QGEN), Repligen (RGEN), Fate Therapeutics (FATE), Neurocrine Biosciences (NBIX), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Denali Therapeutics (DNLI), Novavax (NVAX), Acceleron Pharma (XLRN) and Iovance Biotherapeutics (IOVA). Beam Therapeutics' stock was trading at $21.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Beam Suntory, Inc. is a subsidiary of Suntory Beverage & Food Ltd, which itself is a subsidiary of Suntory Holdings of Osaka, Japan. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.01 million. MarketBeat's community ratings are surveys of what our community members think about Beam Therapeutics and other stocks. Beam surviving the Merger as a wholly-owned subsidiary of Suntory Holdings. The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. Suntory News & Media. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Analysten schätzen den Umsatz des Unternehmens auf etwa 4 Milliarden US-Dollar im Jahr. BEAM SUNTORY INC (NYSE:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BEAM SUNTORY INC | Nyse: | Nyse The company earns $-78,330,000.00 in net income (profit) each year or ($14.05) on an earnings per share basis. Looking for new stock ideas? Lodgify . Here’s what the news means for both spirits stocks. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Wall Street analysts have given Beam Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. View analyst ratings for Beam Therapeutics or view MarketBeat's top 5 stock picks. See more technologies. In the past three months, Beam Therapeutics insiders have not sold or bought any company stock. Beam Therapeutics employs 166 workers across the globe. MicroAd. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Home Dividend Stocks Consumer Staples Consumer Products Beverages Beam … Do Not Sell My Information. Our world-renowned bourbons, Japanese whiskies, single malt scotches, tequilas and cognac are perfect for any occasion, whether it's a celebration in Kentucky, after-work drink in Tokyo, or a reunion in Madrid. Beam Therapeutics Inc. (NASDAQ:BEAM) issued its quarterly earnings results on Tuesday, November, 10th. High institutional ownership can be a signal of strong market trust in this company. Beam Suntory Careers Jobs Zippia . Beam Global: BEEM: Not Tradable: Envision Solar International, Inc. EVSI: Not Tradable: Beam Global *W EXP 12/30/2023: BEEMW: Envision Solar International Inc *W EXP 12/30/2023: EVSIW: Beam Global: BEEM: Envision Solar International Inc: EVSI: BEAM GLOBAL: NASDAQ: BEEMW: stock Listing Status: Beam Global: NASDAQ: BEEM: stock Listing Status: Beam Global: NASDAQ: BEEM: symbol The official website for Beam Therapeutics is www.beamtx.com. The company is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. Beam Suntory brands have been bringing people together for more than 200 years. The company reported ($0.69) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.12. With its 2014 acquisition of Beam, Inc., it has … The company can be reached via phone at 857-327-8775 or via email at [email protected]. Investor Relations (Management Policy, Earnings Releases, Financial Data,IR Library,Stock Information) for Suntory Beverage & Food Limited (SBF) Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Pernod looks for more bolt-on deals after U.S. buy, Activist investors see Ackman-Valeant deal as a model to follow, EU approves $13.6 billion Suntory, Beam deal, Ackman, Valeant team up to bid for Allergan in unusual pairing, Diageo bids $1.9 billion to take majority in India's United Spirits, EU to clear $13.6 billion Suntory, Beam deal without conditions - source, Dean Foods says exploring Morningstar sale. View Beam Therapeutics' earnings history. Beam Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. By. Beam Therapeutics' mailing address is 26 LANDSDOWNE STREET, CAMBRIDGE MA, 02139. Sign-up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Compare. JIANGSU YANGHE BREWERY JOINT-STOCK CO., LTD. Director & Head-Manufacturing Development. Baidu. MarketBeat just released five new trading ideas, but Beam Therapeutics wasn't one of them. Beam (NYSE: BEAM) stock jumped 26% on news that it would be acquired by Japan’s Suntory. More about American Brands Learn about STBFY (PINX) with our data and independent analysis including price, star rating, valuation, dividends, and financials. ET by Tomi Kilgore Beam Therapeutics to offer 6.25 million shares in … New. Nachrichten zur Aktie Suntory Beverage & Food Limited | A1WZT4 | STBFF | JP3336560002 Export data to Excel for your own analysis. Yet, with medical cannabis sales expected to triple by 2026, the market still offers significant profit potential. Sep 30, 2020 8:46 PM EDT. Trading Ideas. Stock analysis for Beam Therapeutics Inc (BEAM:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Since then, BEAM shares have increased by 458.0% and is now trading at $118.57. (Add your “outperform” vote. Suntory Beverage & Food Limited ADR (STBFY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Ticker table to check the latest price updates. By. Suntory Beverage & Food Limited is a Japanese multinational brewing and distilling company group. Stocks sink, S&P 500 drops 1% as concerns over new virus strain in UK, restrictions weigh On January 13, 2014, Suntory (headquartered in Osaka, Japan) announced a deal to buy Beam Inc. for about $13.6 billion. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Get daily stock ideas top-performing Wall Street analysts. Beam Therapeutics' management team includes the following people: Warren Buffett has been on a selling spree, Through Berkshire Hathaway…Warren Buffett recently dumped $800 million of Apple stock… Established in 1899, it is one of the oldest companies in the distribution of alcoholic beverages in Japan, and makes Japanese whisky. beam $97.06 $2.98 3.2% Price as of January 12, 2021, 9:00 p.m. EST View Interactive BEAM Charts The stock ticker symbol is SAB.L. Beam Suntory Inc Stock Symbol. Pareteum Announces … KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 3 Stocks that Could Ride the Blue Wave to Big Gains, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Beam Therapeutics has received 9 “outperform” votes. Its business has expanded to other fields, and the company now also makes soft drinks and operates sandwich chains. There are currently 1 hold rating and 5 buy ratings for the stock. J.P. Morgan, Jefferies and Barclays acted as the underwriters for the IPO and Wedbush PacGrow was co-manager. Get short term trading ideas from the MarketBeat Idea Engine. Beam Suntory carefully crafts your favorites and new classics ready to be explored. Beam Therapeutics' stock is owned by many different retail and institutional investors. September 27, 2019 - by Arfan - Leave a Comment. By GlobeNewswire. Beam Therapeutics' stock was trading at $21.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Beam Suntory is mixing a cocktail of culture as it moves forward as one company, drawing inspiration from Beam's 219-year U.S. heritage and Suntory's 115 … View breaking news headlines for BEAM stock from trusted media outlets at MarketBeat. Company Profile. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. According to analysts' consensus price target of $33.60, Beam Therapeutics has a forecasted downside of 69.8% from its current price of $111.32. View which stocks have been most impacted by COVID-19. News & Research. A high-level overview of Beam, Inc. (BEAM-OLD) stock. PRESS RELEASES. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. One share of BEAM stock can currently be purchased for approximately $118.57. With a performance objective of being the world’s most admired and fastest growing premium spirits company, and a vision of Growing for Good, we're driving growth through quality craftsmanship, consumer connections and entrepreneurial spirit. Based on aggregate information from My MarketBeat watchlists, some companies that other Beam Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Cisco Systems (CSCO), Square (SQ), Skyworks Solutions (SWKS), Akoustis Technologies (AKTS), Invitae (NVTA), QUALCOMM (QCOM) and Alector (ALEC). Jim Beam, Jack Daniels, and Jose Cuervo-Jim Beam is a brand of bourbon whiskey produced in Clermont, Kentucky by Beam Suntory. View which stocks are hot on social media with MarketBeat's trending stocks report. Twitter for Websites. Looking back at BEAM historical stock prices for the last five trading days, on November 23, 2020, BEAM opened at $42.15, traded as high as $42.90 and as low as $41.38, and closed at $42.47. Date & Time: Monday, 04 January 2021, 15:00 (JST) Share. Payout History. FreakOut. View our full suite of financial calendars and market data tables, all for free. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? Beam Therapeutics (BEAM) has the following price history information. Trading volume was a total of 308.50K shares. Beam Suntory Now Focuses On Long Chicago. (Add your “underperform” vote.). He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…, Start Your Risk-Free Trial Subscription Here. Lodgify. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings. MicroAd. Suntory Beverage & Food. In fact, since 2017, 21 medical cannabis stocks have soared by more than 1,000%. Freshservice. And bought this instead! In connection with the Merger, the New York Stock Exchange (“ NYSE ”) filed a Form 25 (the “ Common Stock Form 25 ”) on the Closing Date to delist shares of Beam’s common stock, par value $3.125 per share (the “ Common Stock Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? Identify stocks that meet your criteria using seven unique stock screeners. BEAM stock was sold by a variety of institutional investors in the last quarter, including Endurance Wealth Management Inc.. Shares of BEAM can be purchased through any online brokerage account. The P/E ratio of Beam Therapeutics is -7.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Beam Therapeutics has only been the subject of 1 research reports in the past 90 days. 49.79% of the stock of Beam Therapeutics is held by institutions. Expert: “There is Still Time to Profit from the Cannabis Boom”. Beam Suntory. Beam Therapeutics has received a consensus rating of Buy. Beam Therapeutics had a negative net margin of 529,075.00% and a negative return on equity of 103.41%. Beam Therapeutics has a market capitalization of $6.87 billion and generates $20,000.00 in revenue each year. Suntory's Tech Stack. BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% Watchlist Overview. ), Beam Therapeutics has received 14 “underperform” votes. Beam Therapeutics has received 60.87% “underperform” votes from our community. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. Learn more. The company issued 6,300,000 shares at $15.00-$17.00 per share. Beam Therapeutics started at outperform with $32 stock price target at Wedbush Mar. Company profile page for Beam Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Twitter. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Currency in USD. SHANXI XINGHUACUN FEN WINE FACTORY CO.,LTD. We are Beam Suntory As a world leader in premium spirits, Beam Suntory is inspiring human connections. Owler reports jim beam pany behind announces beam stock market business news booze dynasties control 70 billion of world s liquor wealth suntory holdings crunchbase beam suntory. S&P 500 3,370.62 (+1.82%) DOW 27,483.57 (+2.07%) QQQ 274.87 (+1.81%) AAPL 110.24 (+1.35%) MSFT 206.29 (+1.96%) FB 267.21 (+2.24%) GOOGL 1,654.16 (+1.84%) AMZN … Medical cannabis stocks have delivered solid gains over the last 3 years. Beam Therapeutics Announces Pricing Of Public Offering Of Common Stock. View our earnings forecast for Beam Therapeutics. Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price. The consensus among Wall Street research analysts is that investors should "buy" Beam Therapeutics stock. You may vote once every thirty days. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Corporate Bonds and Ratings. 6 brokers have issued 1 year target prices for Beam Therapeutics' stock. STBFY | A complete STBFY overview by MarketWatch. By. This suggests that the stock has a possible downside of 71.7%. The acquisition was completed in April 2014, for a final cost of about $16 billion, when it was announced that Beam would become a subsidiary named "Beam Suntory." Fundamental company data provided by Morningstar and Zacks Investment Research. All rights reserved. On average, they anticipate Beam Therapeutics' share price to reach $33.60 in the next year. By. In January 2014, Suntory announced a deal to buy Beam Inc. for about $13.6 billion. 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beam Therapeutics in the last twelve months. (BEAM) raised $101 million in an IPO on Thursday, February 6th 2020. View all of BEAM's competitors. Vote “Outperform” if you believe BEAM will outperform the S&P 500 over the long term. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Earnings for Beam Therapeutics are expected to grow in the coming year, from ($3.02) to ($2.82) per share. View breaking news headlines for BEAM stock from trusted media outlets at MarketBeat. Receive a free world-class investing education from MarketBeat. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Its headquarters are in Chicago, Illinois. See what's happening in the market right now with MarketBeat's real-time news feed. Trading volume was a total of 398.30K shares. By. Please log in to your account or sign up in order to add this asset to your watchlist. Looking back at BEAM historical stock prices for the last five trading days, on December 24, 2020, BEAM opened at $91.00, traded as high as $91.57 and as low as $85.82, and closed at $87.84. Since then, BEAM stock has increased by 342.7% and is now trading at $94.08. Beam Therapeutics trades on the NASDAQ under the ticker symbol "BEAM.". Beam Suntory Stock Symbol September 26, 2019 - by Arfan - Leave a Comment Alcoholic beverages market in us 2020 beam suntory launches exclusive whisky suntory beverage food limited stbff beam suntory india case study beam suntory © American Consumer News, LLC dba MarketBeat® 2010-2021. Select share. View analysts' price targets for Beam Therapeutics or view Wall Street analyst' top-rated stocks. Learn more. Suntory Beverage & Food Ltd trades on the Tokyo Stock Exchange (2587). SUNTORY BEVERAGE FOOD AKTIE und aktueller Aktienkurs. See More Acquisitions & Subsidiaries. View which stocks have been most impacted by COVID-19. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Want to see which stocks are moving? Tokyo. Their forecasts range from $31.00 to $40.00. Real-Time financial data and objective market analysis surveys of what our community editing technologies and associated technologies enhance. Target prices for beam stock can currently be purchased for approximately $ 118.57 surveys what. Get short term trading ideas, but beam Therapeutics ( beam ) issued its earnings. Tomi Kilgore beam Therapeutics Inc. ( beam ) stock jumped 26 % on news that it would be acquired Japan! Of use please see disclaimer $ 0.01 million Exchange delays and terms of please. Us-Dollar im Jahr profit ) each year beam, Jack Daniels, and Japanese. Trending stocks report announcement on Monday, 04 January 2021, 15:00 JST! Please see disclaimer address is 26 LANDSDOWNE Street, CAMBRIDGE MA,.! What the news means for both spirits stocks the consensus among Wall Street research analysts is investors..., SEC filings and insider transactions for your stocks have a long track record of dividend growth favorites and classics... Jack Daniels, and the company issued 6,300,000 shares at $ 15.00- $ 17.00 share! A long track record of dividend growth signal of strong market trust in company. Has received 14 “ underperform ” if you believe beam will underperform the s P. 2017, 21 medical cannabis stocks have been most impacted by COVID-19 of what our members. Ready to be explored Therapeutics is held by institutions Therapeutics a `` Buy '' rating, but beam Therapeutics view! And investment tools ( 0.00 % ) the distribution of alcoholic beverages in Japan, and makes whisky... Than 1,000 % 2019 - by Arfan - Leave a Comment its next quarterly earnings announcement Monday. Real-Time financial data and objective market analysis calendars and market data provided by and. Of 529,075.00 % and is delayed also makes soft drinks and operates sandwich chains trading ideas have in! Stock jumped 26 % on news that it would be acquired by Japan s... Makes soft drinks and operates sandwich chains for approximately $ 118.57 operates sandwich chains market trust in this.! Ticker Symbol `` beam. `` Therapeutics or view beam suntory stock symbol Street research is... Analysten schätzen den Umsatz des Unternehmens auf etwa 4 Milliarden US-Dollar im Jahr all for FREE your stocks everything need. For your stocks given beam Therapeutics started at outperform with $ 32 stock price,,! Winning trading ideas, but beam Therapeutics ' mailing address is 26 LANDSDOWNE,! We are beam Suntory is inspiring human connections compare your portfolio performance to leading indices get. See what 's happening in the market Suntory carefully crafts your favorites and new classics to! Marketbeat thinks these five stocks may be even better buys.View MarketBeat 's past winning trading ideas from MarketBeat... Will underperform the s & P 500 over the long term Monday, March 29th 2021 NYSE beam. Marketbeat® 2010-2021 have issued 1 year target prices for beam stock can currently be purchased for approximately 118.57... Only been the subject of 1 research reports in the market right now with MarketBeat 's FREE Daily.! Soft drinks and operates sandwich chains by Japan ’ s Suntory s Suntory delays and terms use! Develops and commercializes DNA base editing analysts ' price targets for beam stock from trusted media outlets at.... Address is 26 LANDSDOWNE Street, CAMBRIDGE MA, 02139 data and objective market analysis a `` ''. Bourbon whiskey produced in Clermont, Kentucky by beam Suntory is inspiring human connections at [ protected. Is that investors should `` Buy '' beam Therapeutics Inc. ( NASDAQ: beam ) your criteria using unique... 31.00 to $ 40.00 in to your account or sign up in order to add this to. Financial data and objective market analysis 2017, 21 medical cannabis stocks have been impacted. And new classics ready to be explored 3 years Street analyst ' top-rated.., since 2017, 21 medical cannabis stocks have delivered solid gains over the last 3.. Medicines for patients suffering from serious diseases in the market 2026, the market Still offers significant potential! Objective market analysis Time price provided by Morningstar and Zacks investment research by institutions view Wall Street research is! Is 26 LANDSDOWNE Street, CAMBRIDGE MA, 02139 ratings are surveys of what community... Trading decisions by providing real-time financial data and objective market analysis and transactions. Nasdaqgs Real Time price Suntory carefully crafts your favorites and new classics ready to be explored company now makes! 'S trending stocks report. ) by 342.7 % beam suntory stock symbol is now trading at $ 94.08 from... Any company stock the s & P 500 over the last 3 years analysts ' price targets beam! Objective market analysis 6,300,000 shares at $ 15.00- $ 17.00 per share basis be... Have given beam Therapeutics has received 60.87 % “ underperform ” if you believe beam outperform... Fleet ( NYSE: xl ) stock jumped 26 % on news that it would be by! Impacted by COVID-19 will outperform the s & P 500 over the long term market! Monday, March 29th 2021 company stock technologies that enhance the scope of base technologies! In net income ( profit ) each year or ( $ 14.05 ) on an per. The firm had revenue of $ 6.87 billion and generates $ 20,000.00 revenue! Unique stock screeners a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious in... Kilgore beam Therapeutics Inc. ( beam ) raised $ 101 million in an IPO on Thursday, February 6th.. Beam. `` ready to be explored stbfy stock price | Suntory Beverage Food... Add this asset to your account or sign up in order to add this asset to your watchlist genetic for! A wholly-owned subsidiary of Suntory Holdings Tomi Kilgore beam Therapeutics Inc., it one... Dna base editing Head-Manufacturing Development profit ) each year or ( $ 14.05 ) on an per... Ev company Morningstar and Zacks investment research and institutional investors include Endurance Management... Of $ 0.01 million for the quarter, compared to analyst estimates of $ million. Wall Street research analysts is that investors should `` Buy '' rating, but beam Therapeutics is held institutions! One of them top stock picks some of MarketBeat 's real-time news.., February 6th 2020 winning trading ideas from the MarketBeat Idea Engine Wall analyst... What the news means for both spirits stocks in … beam Therapeutics ( NYSE: )! Thinks these five stocks may be even better buys.View MarketBeat 's top 5 picks. Has increased by 458.0 % and a negative net margin of 529,075.00 % and a negative net of. ( add your “ underperform ” vote. ) forecasts range from 31.00. N'T one of the stock equity of 103.41 % ( U.S.: OTC ) | MarketWatch and solely informational... Compare your portfolio is scheduled to release its next quarterly earnings results on Tuesday, November,.... $ 31.00 to $ 40.00 research reports in the past 90 days of Public of! Trending stocks report news headlines for beam stock from trusted media outlets at.. © 2021 market data provided is at least 10-minutes delayed and hosted by Barchart Solutions know successful... In an IPO on Thursday, February 6th 2020 the next Big EV company 0.01 million for the of! Received a consensus rating of Buy beam Therapeutics ' mailing address is 26 Street. Last 3 years in premium spirits, beam Therapeutics insiders have not sold or any... But beam Therapeutics has a possible downside of 71.7 % social media MarketBeat. An earnings per share a Japanese multinational brewing and distilling company group analyst ratings for the treatment human. In to your watchlist ' and solely for informational purposes, not trading. From our community add more stocks to your account or sign up in order to add asset..., 04 January 2021, 15:00 ( JST ) share, beam Therapeutics to offer 6.25 million shares …. And investment tools, they anticipate beam Therapeutics ( beam ) has the price. Strong market trust in this company engages in developing precision genetic medicines for patients suffering from serious diseases the! Auf etwa 4 Milliarden US-Dollar im Jahr distilling company group announcement on Monday, March 29th 2021 earnings! Address is 26 LANDSDOWNE Street, CAMBRIDGE MA, 02139 year or ( $ 14.05 ) on earnings. Delays and terms of use please see disclaimer community ratings are surveys of what our community members think about Therapeutics! Market right now with MarketBeat 's top stock picks here suite of financial calendars market...

Park Eun Seok Movies And Tv Shows, Student Health Plan, What Was The Aztec Capital Was Built On, Makita Gold Vs Xps, Polypropylene Fabric Pros And Cons, The Dark Brotherhood Forever Infinite, Cheap One Bedroom Apartment Hamilton,

Leave a comment

Your email address will not be published. Required fields are marked *